enVVeno Medical Corporation (NVNO)
USD 2.26
(-9.07%)
USD 2.26
(-9.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.43 Million USD | -16.95% |
| 2022 | 2.93 Million USD | -11.01% |
| 2021 | 3.29 Million USD | -4.22% |
| 2020 | 3.43 Million USD | 40.74% |
| 2019 | 2.44 Million USD | 60.49% |
| 2018 | 1.52 Million USD | -88.59% |
| 2017 | 13.34 Million USD | 122.34% |
| 2016 | 6 Million USD | -6.97% |
| 2015 | 6.45 Million USD | 78.77% |
| 2014 | 3.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 3.02 Million USD | 17.19% |
| 2024 Q2 | 2.57 Million USD | 4.76% |
| 2024 Q1 | 2.46 Million USD | 1.03% |
| 2023 Q1 | 2.48 Million USD | -15.28% |
| 2023 FY | 2.43 Million USD | -16.95% |
| 2023 Q3 | 3.17 Million USD | -2.9% |
| 2023 Q4 | 2.43 Million USD | -23.4% |
| 2023 Q2 | 3.27 Million USD | 31.8% |
| 2022 Q1 | 2.9 Million USD | -11.77% |
| 2022 Q3 | 2.78 Million USD | -17.46% |
| 2022 Q4 | 2.93 Million USD | 5.28% |
| 2022 Q2 | 3.37 Million USD | 16.06% |
| 2022 FY | 2.93 Million USD | -11.01% |
| 2021 Q2 | 1.47 Million USD | -27.66% |
| 2021 Q1 | 2.04 Million USD | -40.61% |
| 2021 FY | 3.29 Million USD | -4.22% |
| 2021 Q4 | 3.29 Million USD | 194.68% |
| 2021 Q3 | 1.11 Million USD | -24.34% |
| 2020 Q2 | 3.36 Million USD | 20.82% |
| 2020 Q1 | 2.78 Million USD | 13.91% |
| 2020 Q3 | 2.24 Million USD | -33.18% |
| 2020 FY | 3.43 Million USD | 40.74% |
| 2020 Q4 | 3.43 Million USD | 53.04% |
| 2019 Q4 | 2.44 Million USD | -8.37% |
| 2019 FY | 2.44 Million USD | 60.49% |
| 2019 Q3 | 2.66 Million USD | 2.55% |
| 2019 Q2 | 2.6 Million USD | -0.83% |
| 2019 Q1 | 2.62 Million USD | 72.22% |
| 2018 Q3 | 1.89 Million USD | -27.04% |
| 2018 Q4 | 1.52 Million USD | -19.56% |
| 2018 FY | 1.52 Million USD | -88.59% |
| 2018 Q1 | 18.54 Million USD | 38.93% |
| 2018 Q2 | 2.59 Million USD | -86.0% |
| 2017 FY | 13.34 Million USD | 122.34% |
| 2017 Q2 | 8.08 Million USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q3 | 10.09 Million USD | 24.76% |
| 2017 Q4 | 13.34 Million USD | 32.24% |
| 2016 FY | 6 Million USD | -6.97% |
| 2016 Q4 | 6 Million USD | 373.42% |
| 2016 Q3 | 1.26 Million USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2015 FY | 6.45 Million USD | 78.77% |
| 2015 Q4 | 4.65 Million USD | 0.0% |
| 2014 FY | 3.6 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 95.249% |
| BrainsWay Ltd. | 15.31 Million USD | 84.1% |
| Cerus Corporation | 144.3 Million USD | 98.313% |
| Envoy Medical, Inc. | 9.4 Million USD | 74.101% |
| electroCore, Inc. | 8.94 Million USD | 72.778% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 54.418% |
| IceCure Medical Ltd | 4.24 Million USD | 42.665% |
| Inogen, Inc. | 121.38 Million USD | 97.994% |
| OrthoPediatrics Corp. | 72.56 Million USD | 96.644% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 91.768% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 23.474% |
| MaxCyte, Inc. | 36.1 Million USD | 93.256% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -31.77% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -472.563% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.254% |
| PAVmed Inc | 57.13 Million USD | 95.738% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 90.437% |
| RxSight, Inc. | 22.18 Million USD | 89.026% |
| Sight Sciences, Inc. | 46.43 Million USD | 94.756% |
| SI-BONE, Inc. | 61.05 Million USD | 96.011% |
| TELA Bio, Inc. | 59.16 Million USD | 95.885% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 97.863% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 76.403% |
| Acutus Medical, Inc. | 54.83 Million USD | 95.56% |
| Talis Biomedical Corporation | 29.22 Million USD | 91.668% |
| Spectral AI, Inc. | 12.4 Million USD | 80.364% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 89.474% |
| CVRx, Inc. | 39.28 Million USD | 93.801% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 79.637% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -0.235% |
| Bioventus Inc. | 589.79 Million USD | 99.587% |
| Venus Concept Inc. | 107.1 Million USD | 97.726% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 95.287% |
| LivaNova PLC | 1.15 Billion USD | 99.789% |
| 908 Devices Inc. | 37.49 Million USD | 93.505% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.654% |
| Nemaura Medical Inc. | 26.37 Million USD | 90.769% |
| NeuroPace, Inc. | 86.99 Million USD | 97.201% |
| LENSAR, Inc. | 22.4 Million USD | 89.134% |
| Apyx Medical Corporation | 52.31 Million USD | 95.346% |
| Cutera, Inc. | 518.12 Million USD | 99.53% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 91.697% |
| BioSig Technologies, Inc. | 4.68 Million USD | 48.026% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 95.828% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 88.668% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.889% |
| Axonics, Inc. | 82.35 Million USD | 97.043% |
| Outset Medical, Inc. | 190.91 Million USD | 98.725% |
| IRIDEX Corporation | 24.91 Million USD | 90.226% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.036% |
| IRadimed Corporation | 20.73 Million USD | 88.257% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -45.46% |
| INVO Bioscience, Inc. | 19.99 Million USD | 87.822% |
| Telesis Bio, Inc. | 40.87 Million USD | 94.043% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 94.03% |
| Varex Imaging Corporation | 668.6 Million USD | 99.636% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.213% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 31.831% |
| Pulmonx Corporation | 60.63 Million USD | 95.984% |
| Dynatronics Corporation | 11.78 Million USD | 79.33% |
| Modular Medical, Inc. | 2.27 Million USD | -7.174% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 40.084% |
| Semler Scientific, Inc. | 6.27 Million USD | 61.164% |
| InMode Ltd. | 75.91 Million USD | 96.792% |
| Bruker Corporation | 2.83 Billion USD | 99.914% |
| Cytosorbents Corporation | 29.98 Million USD | 91.879% |
| DexCom, Inc. | 4.19 Billion USD | 99.942% |
| Align Technology, Inc. | 2.45 Billion USD | 99.901% |
| Viveve Medical, Inc. | 10.84 Million USD | 77.551% |
| ZimVie Inc. | 795.85 Million USD | 99.694% |
| Movano Inc. | 5.97 Million USD | 59.226% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 97.672% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -472.563% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 79.637% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.619% |
| Profound Medical Corp. | 12.66 Million USD | 80.775% |
| Insulet Corporation | 1.85 Billion USD | 99.869% |
| Surmodics, Inc. | 65.82 Million USD | 96.301% |
| iCAD, Inc. | 8 Million USD | 69.566% |
| Nuwellis, Inc. | 6.78 Million USD | 64.086% |
| Biotricity, Inc. | 35.91 Million USD | 93.221% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.908% |
| Aethlon Medical, Inc. | 2.47 Million USD | 1.801% |
| InspireMD, Inc. | 8.14 Million USD | 70.093% |
| PAVmed Inc. | 57.13 Million USD | 95.738% |
| BIOLASE, Inc. | 35.34 Million USD | 93.111% |
| Beyond Air, Inc. | 29.77 Million USD | 91.822% |
| FONAR Corporation | 57.45 Million USD | 95.762% |
| AxoGen, Inc. | 101.16 Million USD | 97.593% |
| Vivani Medical, Inc. | 25.03 Million USD | 90.274% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 97.227% |
| Inari Medical, Inc. | 209.32 Million USD | 98.837% |
| UFP Technologies, Inc. | 118.04 Million USD | 97.937% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 80.812% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -11.4% |
| Tenon Medical, Inc. | 5.56 Million USD | 56.26% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -36.875% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 86.192% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.923% |
| Sintx Technologies, Inc. | 6.59 Million USD | 63.067% |
| NanoVibronix, Inc. | 2.68 Million USD | 9.345% |
| Quanterix Corporation | 78.08 Million USD | 96.882% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 31.831% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 50.154% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.767% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.572% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 85.403% |
| NeuroMetrix, Inc. | 1.33 Million USD | -82.654% |
| Hyperfine, Inc. | 9.8 Million USD | 75.153% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.027% |
| Biomerica, Inc. | 2.66 Million USD | 8.562% |
| Bone Biologics Corporation | 831.4 Thousand USD | -192.879% |
| AVITA Medical, Inc. | 19.86 Million USD | 87.743% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -23.373% |
| Silk Road Medical, Inc | 114.15 Million USD | 97.867% |